rs1554292741
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PP3_StrongPP5
The NM_000535.7(PMS2):c.2534A>T(p.His845Leu) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 10
GnomAD4 exome Cov.: 10
GnomAD4 genome Cov.: 10
ClinVar
Submissions by phenotype
Lynch syndrome 4;C5436817:Mismatch repair cancer syndrome 4 Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.H845L variant (also known as c.2534A>T), located in coding exon 15 of the PMS2 gene, results from an A to T substitution at nucleotide position 2534. The histidine at codon 845 is replaced by leucine, an amino acid with similar properties. This variant has been reported in individuals with colorectal cancer with tumor tissue showing MSI-H and loss of PMS2 by IHC analysis (Goodenberger ML et al. Genet. Med., 2016 Jan;18:13-9; Yurgelun et al. J Clin Oncol 2017 Apr;35(10):1086-1095). Based on internal structural assessment, this alteration disrupts the Zinc-binding exonuclease site (Gueneau E et al., Nat. Struct. Mol. Biol. 2013 Apr; 20(4):461-8). This missense alteration is located in a region that has a low rate of benign missense variation (Lek M et al. Nature. 2016 Aug 18;536(7616):285-91; DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth H.V. et al. 2009. Am.J.Hum.Genet. 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)). This amino acid position is highly conserved in available vertebrate species. The in silico prediction for this alteration is inconclusive. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this alteration is likely to be pathogenic. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with Lynch-related cancers and consistent tumor studies (Goodenberger et al., 2016); This variant is associated with the following publications: (PMID: 18619468, Fukui2011[Chapter], 25856668, 28135145) -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change replaces histidine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 845 of the PMS2 protein (p.His845Leu). The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This missense change has been observed in individual(s) with colorectal cancer (PMID: 25856668, 28135145). ClinVar contains an entry for this variant (Variation ID: 480297). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is expected to disrupt PMS2 function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at